Bottom line
RYHIX vs PINK: the short answer
RYHIX (Health Care Fund) and PINK (Simplify Health Care ETF) share a meaningful slice of their top holdings — about 45% by weight.
But RYHIX is far broader, holding 135 positions to 54 for PINK, so beyond the top names it adds exposure PINK doesn't have.
PINK is cheaper at 0.51% vs 1.38% — a difference of $87 a year per $10,000 invested.
Over one year, PINK returned +24.1% vs +14.4% for RYHIX.
Updated Nov 19, 2026
RYHIX vs PINK side by side
| RYHIX | PINK | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Guggenheim | Simplify Exchange Traded |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.38% | 0.51% |
| Annual cost per $10k | $138 | $51 |
| 10-yr cost on $10k (prospectus) | $1,709 | $641 |
| Max front load | — | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +14.4% | +24.1% |
| 5-yr return (annualized) | +5.1% | — |
| 10-yr return (annualized) | +7.9% | — |
| Best quarter | +18.7% | +15.6% |
| Worst quarter | −14.4% | −9.5% |
| Net assets (fund) | $19.4M | $358.6M |
| Number of holdings | 135 | 54 |
| Portfolio turnover | 244% | 171% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | RYHIX | PINK | Difference |
|---|---|---|---|
| 2025 | +14.4% | +24.1% | −9.6% |
| 2024 | +0.6% | +8.9% | −8.3% |
| 2023 | +5.8% | +3.8% | +2.1% |
| 2022 | −11.6% | −4.3% | −7.3% |
Source: Fund prospectus bar charts
Holdings overlap
13 of RYHIX's top 25 holdings also appear in PINK's top 25.
| Holding | RYHIX | PINK |
|---|---|---|
| Eli Lilly & Company | 3.63% | 5.91% |
| Johnson & Johnson | 2.88% | 5.45% |
| Abbvie Inc | 2.52% | 4.52% |
| Unitedhealth Group Inc | 2.22% | 5.76% |
| Thermo Fisher Scientific Inc | 1.61% | 3.23% |
| Amgen Inc | 1.56% | 2.12% |
| Gilead Sciences Inc | 1.39% | 2.87% |
| Vertex Pharmaceuticals Inc | 1.34% | 1.45% |
| Cvs Health Corp | 1.31% | 2.01% |
| Danaher Corp | 1.30% | 2.28% |
| Elevance Health Inc | 1.02% | 2.73% |
| Cardinal Health Inc | 0.86% | 1.78% |
| Novo Nordisk A/s | 0.83% | 6.75% |
Source: SEC Form N-PORT
RYHIX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
PINK top 10
- Purecycle Technologies Inc — 6.89%
- United Therapeutics Corp — 6.86%
- Novo Nordisk A/s — 6.75%
- Eli Lilly & Company — 5.91%
- Unitedhealth Group Inc — 5.76%
- Warby Parker Inc — 5.46%
- Johnson & Johnson — 5.45%
- Jazz Pharmaceuticals Plc — 4.61%
- Abbvie Inc — 4.52%
- Biohaven Ltd — 4.32%
FAQ
What is the difference between RYHIX and PINK?
Which is cheaper, RYHIX or PINK?
Should I own both RYHIX and PINK?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.